Massa Medicata Fermentata (MMF) processed by stir-frying reduces Helicobacter pylori burden in a gastritis mouse model
Ethnopharmacological relevance Helicobacter pylori ( H. pylori ) is the only confirmed pathogenic bacterium that can persistently colonize the stomach and cause gastric mucosal inflammation and related diseases. Massa Medicata Fermentata (MMF), a classical traditional fermented Chinese medicine, is commonly used clinically—either unprocessed or stir-fried—to treat gastric disorders such as dyspepsia; however, its pharmacological mechanisms against H. pylori infection remain unclear. Objective To comparatively analyze the antibacterial effects of naturally fermented MMF and its stir-fried MMF on H. pylori in vivo and in vitro . Materials and method Naturally fermented MMF was stir-fry processed for different durations to produce three types: golden-, aromatic-, and charred-MMF; their biochemical characteristics and components were then evaluated. Co-culture experiments assessed the effects of MMF on H. pylori growth in vitro . Finally, a mouse H. pylori infection model was established; interventions with the four MMF types, alone or combined with anti- H. pylori immunoglobulin Y (IgY- Hp ), were administered for 2 weeks, and both H. pylori burden and gastrointestinal function were measured. Results Naturally fermented MMF exerted a direct effect on the growth and infection of H. pylori . Stir-fry processing not only markedly altered MMF appearance and biochemical profiles, but also enhanced its inhibitory activity against H. pylori growth. In H. pylori –infected mice, aromatic- and charred-MMF reduced gastric H. pylori burden, with 37.5% of treated animals (3/8) testing RUT-negative versus 25% for original MMF. Interestingly, combining MMF with IgY- Hp further enhanced the anti- H. pylori activity of MMF; notably, the aromatic-MMF + IgY- Hp group demonstrated a synergistic inhibitory effect on H. pylori growth (FICI = 0.5) and achieved the largest reduction in H. pylori burden in vivo , with 62.5% of treated animals (5/8) testing RUT-negative. This group also showed significantly improved gastrointestinal function, including gastric emptying and small-intestinal propulsion (p < 0.05), as well as serum gastrin, motilin, and somatostatin levels. Further GC-MS analysis revealed that stir-frying markedly altered the chemical components of MMF, such as 5-hydroxymethylfurfural (5-HMF) and 1-Ethyl-2-formylpyrrole, whose changes are consistent with the variation in antibacterial activity of stir-fried MMF. Conclusion Stir-fry processing significantly altered the appearance, biochemical profile, and composition of MMF and exerted a significantly stronger anti- H. pylori effect, especially for aromatic-MMF, compared with naturally fermented MMF. In addition, MMF combined with IgY- Hp significantly increased antibacterial activity in vitro and in vivo and promoted recovery of gastrointestinal function, suggesting a potentially effective and non-antibiotic therapeutic option.
Authors
- Xiao‐Hong Jian
- 小玲 骆
- Rong Guo (ORCID: https://orcid.org/0009-0000-7296-1976)
- Nanlin Chen
- Zaixin Li
- Zhi Zhang
- Ruilin Xie
- Bin Wang
- Hao Jiang
- Meifang Du
- Taibing Yang
Institutions
- Yibin University (CN)
- Sichuan University of Science and Engineering (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fphar.2026.1934298
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00